HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jordan D Berlin Selected Research
Jordan D Berlin Research Topics
Disease
32
Neoplasms (Cancer)
01/2022 - 08/2002
17
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2002
15
Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 08/2002
7
Nausea
01/2022 - 02/2012
6
Fatigue
01/2022 - 08/2008
5
Neutropenia
01/2020 - 01/2004
4
Neoplasm Metastasis (Metastasis)
10/2018 - 08/2002
4
Adenocarcinoma
01/2014 - 01/2005
3
Diarrhea
01/2022 - 02/2012
3
Vomiting
01/2022 - 04/2013
3
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2019 - 10/2004
2
Fever (Fevers)
01/2022 - 08/2008
2
Microsatellite Instability
01/2018 - 09/2013
2
Hypersensitivity (Allergy)
07/2012 - 08/2007
1
Anemia
01/2022
1
Edema (Dropsy)
01/2022
1
Exanthema (Rash)
01/2022
1
Melanoma (Melanoma, Malignant)
01/2022
1
Aseptic Meningitis
01/2022
1
Chromosomal Instability (Chromosome Stability)
01/2019
1
Cytopenia
01/2019
1
Dehydration (Water Stress)
01/2019
1
Liver Diseases (Liver Disease)
01/2018
1
Rectal Neoplasms (Rectal Cancer)
01/2018
1
Thrombocytopenia (Thrombopenia)
01/2016
1
Disease Progression
08/2014
1
Clinical Deterioration
06/2014
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
02/2013
1
Fatty Liver
02/2013
1
Stroke (Strokes)
07/2012
Drug/Important Bio-Agent (IBA)
11
Irinotecan (Camptosar)
FDA Link
Generic
01/2020 - 08/2002
9
Gemcitabine
FDA Link
01/2018 - 08/2002
9
Fluorouracil (Carac)
FDA Link
Generic
01/2014 - 08/2002
6
Cetuximab (Erbitux)
FDA Link
01/2018 - 10/2004
5
Leucovorin (Folinic Acid)
FDA Link
01/2014 - 08/2002
5
ErbB Receptors (EGF Receptor)
IBA
01/2012 - 10/2004
4
Monoclonal Antibodies
IBA
01/2017 - 04/2013
4
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2014 - 06/2003
3
Bevacizumab (Avastin)
FDA Link
01/2020 - 01/2008
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022 - 01/2017
2
veliparib
IBA
08/2019 - 01/2019
2
MLN 8237
IBA
01/2019 - 12/2018
2
Aurora Kinase A
IBA
01/2019 - 12/2018
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 10/2004
2
Cytotoxins (Cytolysins)
IBA
01/2018 - 05/2003
2
Pharmaceutical Preparations
IBA
01/2017 - 08/2002
2
Capecitabine (Xeloda)
FDA Link
01/2016 - 02/2012
2
KRN-330
IBA
08/2014 - 04/2013
2
Thymidylate Synthase
IBA
01/2014 - 12/2008
2
DNA (Deoxyribonucleic Acid)
IBA
06/2011 - 01/2004
2
Biological Products
IBA
12/2008 - 12/2005
2
Ligands
IBA
02/2005 - 10/2004
1
Glutamine (L-Glutamine)
FDA Link
01/2022
1
epacadostat
IBA
01/2022
1
parsaclisib
IBA
01/2022
1
itacitinib
IBA
01/2022
1
binimetinib
IBA
01/2022
1
Blood Proteins (Serum Proteins)
IBA
01/2022
1
Creatine Kinase (Creatine Phosphokinase)
IBA
01/2022
1
ribociclib
IBA
01/2022
1
larotrectinib
IBA
01/2020
1
Alanine Transaminase (SGPT)
IBA
01/2020
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2020
1
trifluridine tipiracil drug combination
IBA
01/2020
1
B7-H1 Antigen
IBA
01/2019
1
Platinum
IBA
01/2019
1
ibrutinib
IBA
01/2019
1
Immune Checkpoint Inhibitors
IBA
01/2019
1
durvalumab
IBA
01/2019
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2019
1
1- (3- (1- methyl- 1H- pyrazol- 4- yl)- 5- oxo- 5H- benzo(4,5)cyclohepta(1,2- b)pyridin- 7- yl)- N- (pyridin- 2- ylmethyl)methanesulfonamide
IBA
10/2018
1
STA 9090
IBA
01/2018
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
01/2018
1
Cell Adhesion Molecules
IBA
10/2017
1
Carcinoembryonic Antigen
IBA
10/2017
1
Immunoconjugates (Immunoconjugate)
IBA
10/2017
1
labetuzumab govitecan
IBA
10/2017
1
Mitogen-Activated Protein Kinases
IBA
01/2017
1
linifanib
IBA
01/2017
1
LY3022859
IBA
01/2017
1
cobimetinib
IBA
01/2017
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2016
1
Amylases
FDA Link
01/2016
1
Activin Receptors (Activin Receptor)
IBA
01/2016
1
Vorinostat
FDA Link
01/2016
1
ascrinvacumab
IBA
01/2016
1
Lipase (Acid Lipase)
FDA Link
01/2016
1
Differentiation Antigens
IBA
08/2014
1
folfirinox
IBA
01/2014
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2014
1
130-nm albumin-bound paclitaxel
IBA
01/2014
1
Paraffin
IBA
09/2013
1
Glycoproteins (Glycoprotein)
IBA
04/2013
Therapy/Procedure
21
Therapeutics
01/2019 - 08/2002
8
Drug Therapy (Chemotherapy)
01/2018 - 05/2003
3
Neoadjuvant Therapy
08/2013 - 05/2007
1
Immunotherapy
01/2016
1
Pancreatectomy
08/2013
1
Hepatectomy
02/2013
1
Biological Therapy
02/2013